Literature DB >> 11943163

Direct interaction of soluble human recombinant tau protein with Abeta 1-42 results in tau aggregation and hyperphosphorylation by tau protein kinase II.

Kenneth B Rank1, Adele M Pauley, Keshab Bhattacharya, Zhigang Wang, David B Evans, Timothy J Fleck, Jennifer A Johnston, Satish K Sharma.   

Abstract

We report here that aggregated beta-amyloid (Abeta) 1-42 promotes tau aggregation in vitro in a dose-dependent manner. When Abeta-mediated aggregated tau was used as a substrate for tau protein kinase II (TPK II), an 8-fold increase in the rate of TPK II-mediated tau phosphorylation was observed. The extent of TPK II-dependent tau phosphorylation increased as a function of time and Abeta 1-42 concentration, and hyperphosphorylated tau was found to be decorated with an Alzheimer's disease-related phosphoepitope (P-Thr-231). In HEK 293 cells co-expressing CT-100 amyloid precursor protein and tau, the release of Abeta 1-42 from these cells was impaired. Taken together, these in vitro results suggest that Abeta 1-42 promotes both tau aggregation and hyperphosphorylation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11943163     DOI: 10.1016/s0014-5793(02)02376-1

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  14 in total

1.  The γ-secretase modulator CHF5074 reduces the accumulation of native hyperphosphorylated tau in a transgenic mouse model of Alzheimer's disease.

Authors:  Annamaria Lanzillotta; Ilenia Sarnico; Marina Benarese; Caterina Branca; Cristina Baiguera; Birgit Hutter-Paier; Manfred Windisch; Pierfranco Spano; Bruno Pietro Imbimbo; Marina Pizzi
Journal:  J Mol Neurosci       Date:  2010-12-22       Impact factor: 3.444

2.  Dependence of the Formation of Tau and Aβ Peptide Mixed Aggregates on the Secondary Structure of the N-Terminal Region of Aβ.

Authors:  Ana V Rojas; Gia G Maisuradze; Harold A Scheraga
Journal:  J Phys Chem B       Date:  2018-07-10       Impact factor: 2.991

Review 3.  Neurological dysfunctions associated with altered BACE1-dependent Neuregulin-1 signaling.

Authors:  Xiangyou Hu; Qingyuan Fan; Hailong Hou; Riqiang Yan
Journal:  J Neurochem       Date:  2015-11-13       Impact factor: 5.372

4.  Proteins recruited to exosomes by tau overexpression implicate novel cellular mechanisms linking tau secretion with Alzheimer's disease.

Authors:  Sudad Saman; Norman C Y Lee; Itoro Inoyo; Jun Jin; Zhihan Li; Thomas Doyle; Ann C McKee; Garth F Hall
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

5.  Abeta and tau form soluble complexes that may promote self aggregation of both into the insoluble forms observed in Alzheimer's disease.

Authors:  Jian-Ping Guo; Tetsuaki Arai; Judit Miklossy; Patrick L McGeer
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-30       Impact factor: 11.205

6.  Probing Protein Aggregation Using the Coarse-Grained UNRES Force Field.

Authors:  Ana V Rojas; Gia G Maisuradze; Harold A Scheraga; Adam Liwo
Journal:  Methods Mol Biol       Date:  2022

7.  Postsynaptic dysfunction is associated with spatial and object recognition memory loss in a natural model of Alzheimer's disease.

Authors:  Alvaro O Ardiles; Cheril C Tapia-Rojas; Madhuchhanda Mandal; Frédéric Alexandre; Alfredo Kirkwood; Nibaldo C Inestrosa; Adrian G Palacios
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-06       Impact factor: 11.205

8.  Cerebrospinal fluid markers in Creutzfeldt-Jakob disease.

Authors:  Anders Skinningsrud; Vidar Stenset; Astrid S Gundersen; Tormod Fladby
Journal:  Cerebrospinal Fluid Res       Date:  2008-08-27

9.  The role of heat shock protein 70 in the protective effect of YC-1 on β-amyloid-induced toxicity in differentiated PC12 cells.

Authors:  Yung-Chieh Tsai; Yen-Mei Lee; Kwok-Keung Lam; Jui-Fen Lin; Jhi-Joung Wang; Mao-Hsiung Yen; Pao-Yun Cheng
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

Review 10.  Tau protein modifications and interactions: their role in function and dysfunction.

Authors:  Anna Mietelska-Porowska; Urszula Wasik; Marcelina Goras; Anna Filipek; Grazyna Niewiadomska
Journal:  Int J Mol Sci       Date:  2014-03-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.